TBIO
Telesis Bio Inc

3,386
Loading...
Loading...
News
all
press releases
What's Going On With Telesis Bio Shares Thursday?
Telesis Bio shares are moving higher on Thursday after the company announced a partnership with Beckman Coulter Life Sciences. read more...
Benzinga·1y ago
News Placeholder
More News
News Placeholder
Telesis Bio Stock Is Soaring Wednesday: What's Going On?
Telesis Bio shares are soaring in extended trading Wednesday after the company announced a partnership to revolutionize DNA and mRNA synthesis. read more...
Benzinga·1y ago
News Placeholder
TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips TBIO stock results show that Telesis Bio missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of...
InvestorPlace·1y ago
News Placeholder
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced...
Globe Newswire·1y ago
News Placeholder
12 titres de soins de sant en mouvement lors de la session apr s-cl ture le 08/03/2024
Gagnants L'action Genelux (NASDAQ:GNLX) a mont vendredi de 10,06% 7 dollars lors de la session after-market. L'action Telesis Bio (NASDAQ:TBIO) a mont de 9,28% 0,60 dollars. Le titre Estrella...
Benzinga·2y ago
News Placeholder
12 titoli sanitari in movimento, after-market del 08/03/2024
Titoli in rialzo Le azioni di Genelux (NASDAQ:GNLX) hanno fatto segnare +10,06% a 7 dollari durante la sessione after-market di venerd . Il titolo Telesis Bio (NASDAQ:TBIO) ha avuto un aumento del...
Benzinga·2y ago
News Placeholder
Telesis Bio, Inc. (NASDAQ:TBIO) Sees Large Decline in Short Interest
Telesis Bio, Inc. (NASDAQ:TBIO Get Free Report) was the target of a significant decrease in short interest in February. As of February 15th, there was short interest totalling 131,400 shares...
Zolmax·2y ago
News Placeholder
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
Telesis Bio announces Q4 and full-year 2023 select preliminary financial results, highlighting strong BioXp kit sales, expanding gross margin and reduced expenseSAN DIEGO, Feb. 26, 2024 (GLOBE...
Globe Newswire·2y ago

Latest TBIO News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.